Cuzin L - Search Results

1

Low-level viral loads and virological failure in the integrase strand transfer era.

Cuzin L, Flandre P, Allavena C, Palich R, Duvivier C, Becker A, Laroche H, Pugliese P, Cabie A; Dat’AIDS Study Group. Cuzin L, et al. J Antimicrob Chemother. 2023 Apr 3;78(4):1111-1116. doi: 10.1093/jac/dkad056. J Antimicrob Chemother. 2023. PMID: 36879512

2

An example of nonrandom missing data for hepatitis C virus status in a prognostic study among HIV-infected patients.

Lewden C, Jacqmin-Gadda H, Vildé JL, Bricaire F, Waldner-Combernoux A, May T, Cuzin L, Lang JM, Leport C, Chêne G; APROCO Study Group. Lewden C, et al. Among authors: cuzin l. HIV Clin Trials. 2004 Jul-Aug;5(4):224-31. doi: 10.1310/X9AE-5F0Y-AE92-G1NA. HIV Clin Trials. 2004. PMID: 15472797

3

[Analysis of antiretroviral drugs-induced adverse effects].

Baudrant M, Bagheri H, Cuzin L, Sommet A, Bassoua V, Guitton E, Bonnet E, Garipuy D, Lucas F, Aquilina C, Montastruc JL, Massip P. Baudrant M, et al. Among authors: cuzin l. Therapie. 2006 Mar-Apr;61(2):171-6. Therapie. 2006. PMID: 16886711 French.

4

Analyse des effets indésirables des médicaments du VIH.

Bandrant M, Bagheri H, Cuzin L, Sommet A, Bassoua V, Guitton E, Bonnet E, Garipuy D, Lucas F, Aquilina C, Montastruc JL, Massip P. Bandrant M, et al. Among authors: cuzin l. Therapie. 2006 Mar-Apr;61(2):171-6. doi: 10.2515/therapie:2006024. Therapie. 2006. PMID: 27393319 French.

5

Factors associated with mortality in human immunodeficiency virus type 1-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 study). The Antiprotéases Cohorte Agence Nationale de Recherches sur le SIDA EP 11 study.

Lewden C, Raffi F, Cuzin L, Cailleton V, Vildé JL, Chêne G, Allavena C, Salamon R, Leport C. Lewden C, et al. Among authors: cuzin l. J Infect Dis. 2002 Sep 1;186(5):710-4. doi: 10.1086/342047. Epub 2002 Jul 29. J Infect Dis. 2002. PMID: 12195361 Clinical Trial.

6

Enfuvirtide for prophylaxis against HIV infection.

Cuzin L, Alvarez M. Cuzin L, et al. N Engl J Med. 2003 Nov 27;349(22):2169-70; author reply 2169-70. doi: 10.1056/NEJM200311273492218. N Engl J Med. 2003. PMID: 14645649 No abstract available.

7

A systematic review of computer-based patient record systems and quality of care: more randomized clinical trials or a broader approach?

Delpierre C, Cuzin L, Fillaux J, Alvarez M, Massip P, Lang T. Delpierre C, et al. Among authors: cuzin l. Int J Qual Health Care. 2004 Oct;16(5):407-16. doi: 10.1093/intqhc/mzh064. Int J Qual Health Care. 2004. PMID: 15375102 Review.

8

Routine testing to reduce late HIV diagnosis in France.

Delpierre C, Cuzin L, Lert F. Delpierre C, et al. Among authors: cuzin l. BMJ. 2007 Jun 30;334(7608):1354-6. doi: 10.1136/bmj.39225.458218.94. BMJ. 2007. PMID: 17600025 Free PMC article. Review.

9

Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years.

Cuzin L, Delpierre C, Gerard S, Massip P, Marchou B. Cuzin L, et al. Clin Infect Dis. 2007 Sep 1;45(5):654-7. doi: 10.1086/520652. Epub 2007 Jul 19. Clin Infect Dis. 2007. PMID: 17683004

10

Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?

Cuzin L, Allavena C, Morlat P, Dellamonica P. Cuzin L, et al. AIDS Rev. 2008 Oct-Dec;10(4):205-11. AIDS Rev. 2008. PMID: 19092976 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page